Terms: = Skin cancer AND SOCS1, O15524, 8651, ENSG00000185338, SOCS-1, SSI-1, SSI1, Cish1, JAB, CISH1, CIS1, TIP3 AND Treatment
12 results:
1. Effects of extracellular vesicles from adipose-derived stem cells on human keloid fibroblasts via the socs1/JAK2/STAT3 pathway.
Ruan H; Wang J; Shi H; Luan W
J Cosmet Dermatol; 2024 Apr; 23(4):1404-1416. PubMed ID: 38288516
[TBL] [Abstract] [Full Text] [Related]
2. SOCS3 inhibits the pathological effects of IL-22 in non-melanoma skin tumor-derived keratinocytes.
Madonna S; Scarponi C; Morelli M; Sestito R; Scognamiglio PL; Marasco D; Albanesi C
Oncotarget; 2017 Apr; 8(15):24652-24667. PubMed ID: 28445952
[TBL] [Abstract] [Full Text] [Related]
3. Suppressor of cytokine signalling-1 induces significant preclinical antitumor effect in malignant melanoma cells.
Tagami-Nagata N; Serada S; Fujimoto M; Tanemura A; Nakatsuka R; Ohkawara T; Murota H; Kishimoto T; Katayama I; Naka T
Exp Dermatol; 2015 Nov; 24(11):864-71. PubMed ID: 26173926
[TBL] [Abstract] [Full Text] [Related]
4. Effects of suppressor of cytokine signaling 1 silencing on human melanoma cell proliferation and interferon-γ sensitivity.
Xu Y; Wang W; Gou A; Li H; Tian Y; Yao M; Yang R
Mol Med Rep; 2015 Jan; 11(1):583-8. PubMed ID: 25322862
[TBL] [Abstract] [Full Text] [Related]
5. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of socs1.
Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study).
Busse A; Rapion J; Fusi A; Suciu S; Nonnenmacher A; Santinami M; Kruit WH; Testori A; Punt CJ; Dalgleish AG; Spatz A; Eggermont AM; Keilholz U
Cancer Immunol Immunother; 2013 Jul; 62(7):1223-33. PubMed ID: 23624802
[TBL] [Abstract] [Full Text] [Related]
7. Epigenetic lesions in malignant melanoma.
Schwabe M; Lübbert M
Curr Pharm Biotechnol; 2007 Dec; 8(6):382-7. PubMed ID: 18289047
[TBL] [Abstract] [Full Text] [Related]
8. Development of IFN-gamma resistance is associated with attenuation of SOCS genes induction and constitutive expression of SOCS 3 in melanoma cells.
Fojtova M; Boudny V; Kovarik A; Lauerova L; Adamkova L; Souckova K; Jarkovsky J; Kovarik J
Br J Cancer; 2007 Jul; 97(2):231-7. PubMed ID: 17579625
[TBL] [Abstract] [Full Text] [Related]
9. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
Kissel CK; Schadendorf D; Röckmann H
Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454
[TBL] [Abstract] [Full Text] [Related]
10. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE
Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993
[TBL] [Abstract] [Full Text] [Related]
11. Combined effect of proteasome and calpain inhibition on cisplatin-resistant human melanoma cells.
Młynarczuk-Biały I; Roeckmann H; Kuckelkorn U; Schmidt B; Umbreen S; Gołab J; Ludwig A; Montag C; Wiebusch L; Hagemeier C; Schadendorf D; Kloetzel PM; Seifert U
Cancer Res; 2006 Aug; 66(15):7598-605. PubMed ID: 16885359
[TBL] [Abstract] [Full Text] [Related]
12. Aliphatic and alicyclic diols induce melanogenesis in cultured cells and guinea pig skin.
Brown DA; Ren WY; Khorlin A; Lesiak K; Conklin D; Watanabe KA; Seidman MM; George J
J Invest Dermatol; 1998 Apr; 110(4):428-37. PubMed ID: 9540987
[TBL] [Abstract] [Full Text] [Related]
